Thank you for your commitment to advancing meaningful research.
Reflections and Insights from a Year of Collaboration
Across more than15 clinical studies this year, we observed a consistent and meaningful trend: when objective, sensor-derived measures are combined with traditional clinical assessments, teams gain clearer and earlier indications of signal change.
This integrated approach has proved to strengthen interpretability, reduce noise, and offer a more complete picture of participant experience. These insights were shaped through the thoughtful work of our partners and the shared commitment to bring stronger evidence forward. As we carry these learnings into the future, we are expanding our focus on thoughtful, measurement-driven study design and preparing new approaches that will support clearer, more confident decision-making in the year ahead.
What's In Store For Koneksa?
In 2026, we are deepening our focus on thoughtful measurement design and multi-measure evidence generation. Our aim is to help teams gain earlier clarity by delivering signals that are intentionally designed, collected reliably, and interpreted through the scientific relationships that matter most.
-
We are expanding our measurement-science frameworks to integrate digital, physiological, clinical, and contextual signals, giving sponsors a more complete and interpretable view of progression and treatment effect.
​​
-
These enhancements are strengthening the scientific foundation that supports earlier, more confident decision-making.
​
-
Together, these efforts reflect the next chapter of Koneksa: a measurement-science partner committed to clearer signals, stronger models, and better evidence for the decisions that shape development.
Hypothesis
Design
Measures
Learning
Insight
Advancing the Next Phase of Our Modeling Capabilities​
-
Improved methods to identify confounders
-
Enhanced ability to track disease trajectories
-
Greater sensitivity for more precise signal detection
-
Evolving toward a predictive and adaptive approach to trial design
Improved early signal detection in a rare disease study through integrated multimodal measurement
Identified mobility as a hidden confounder in a pain study, transforming what appeared to be a negative outcome into a coherent, biologically meaningful result
Developed a cardiac modeling framework integrating imaging, functional assessments, and digital measures
Designed multi-measure strategies that reduced noise and strengthened sensitivity across motor and functional measures for neurodegenerative disease studies
Aligned sensor-derived mobility measures with PROs, revealing a clearer and clinically coherent pain signal
Optimized trial design for a 2026 cardiovascular first-in-human program, strengthening endpoint and evidence strategy
Thank You
for your partnership, your curiosity, and your commitment to advancing evidence for participants and patients.
Whether we collaborated this year or are beginning new conversations, we look forward to supporting your work in 2026 with the rigor, scientific depth, and measurement strategies that define our platform.
If you'd like to explore how designed measurement or advanced modeling could strengthen your upcoming studies, contact us today.
